GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
J

Jiangsu Yahong Meditech Co 688176.SS · CNY

Health Care · Shanghai · 🇨🇳 China

Compare

11.18

-1.41%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥277.1m

FY2018FY2025

Net income

−CN¥419.3m

FY2018FY2025

Free cash flow

−CN¥430.9m

FY2018FY2025

Shareholders' equity

CN¥1.58bn

FY2018FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
RevenueCN¥277.1mCN¥201.6mCN¥13.8mCN¥26,095CN¥4,574———
Gross profitCN¥277.1mCN¥151.2mCN¥10.8m−CN¥1.8m−CN¥1.2m−CN¥204,632—−CN¥388,100
Research and developmentCN¥282.6mCN¥311.9mCN¥364.6mCN¥243.9mCN¥190.7mCN¥172.0mCN¥141.9mCN¥49.8m
Operating income−CN¥435.4m−CN¥383.8m−CN¥404.0m−CN¥247.6m−CN¥238.4m−CN¥247.0m−CN¥172.1m−CN¥59.9m
Net income−CN¥419.3m−CN¥384.1m−CN¥400.4m−CN¥246.5m−CN¥234.9m−CN¥247.3m−CN¥172.4m−CN¥59.9m
Diluted earnings per share-0.78-0.68-0.69-0.40-0.52-0.54-0.32-0.11

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Total assetsCN¥2.06bnCN¥2.22bnCN¥2.63bnCN¥2.87bnCN¥3.10bnCN¥849.4mCN¥72.7mCN¥66.1m
Cash and short-term investments—CN¥1.29bnCN¥2.33bnCN¥2.74bnCN¥2.98bnCN¥798.7mCN¥56.2mCN¥28.8m
Total liabilitiesCN¥494.4mCN¥252.6mCN¥242.5mCN¥103.0mCN¥86.0mCN¥42.9mCN¥44.0mCN¥18.9m
DebtCN¥48.4mCN¥116.2mCN¥124.2mCN¥18.7mCN¥17.4mCN¥5.8mCN¥87,831CN¥77,849
Shareholders' equityCN¥1.58bnCN¥1.97bnCN¥2.39bnCN¥2.77bnCN¥3.01bnCN¥806.5mCN¥28.8mCN¥47.2m
Shares outstanding539m566m577m609m452m456m539m539m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations−CN¥411.8m−CN¥425.0m−CN¥398.2m−CN¥242.0m−CN¥171.5m−CN¥126.0m−CN¥88.8m−CN¥52.8m
Capital spending−CN¥19.1m−CN¥5.8m−CN¥101.6m−CN¥26.6m−CN¥42.4m−CN¥14.3m−CN¥750,191−CN¥8.5m
Free cash flow−CN¥430.9m−CN¥430.7m−CN¥499.8m−CN¥268.6m−CN¥213.9m−CN¥140.3m−CN¥89.6m−CN¥61.3m
Dividends paid−CN¥4.1m−CN¥2.5m−CN¥411,984——−CN¥361,023−CN¥20,083−CN¥122,447

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCN¥84.3mCN¥71.1mCN¥60.7mCN¥86.2mCN¥69.1mCN¥61.1mCN¥62.6mCN¥58.5m
Gross profitCN¥63.8mCN¥51.6mCN¥115.3mCN¥66.5mCN¥47.1mCN¥48.2mCN¥40.9mCN¥48.1m
Operating income−CN¥133.8m−CN¥115.3m−CN¥173.1m−CN¥90.7m−CN¥82.1m−CN¥84.3m−CN¥115.1m−CN¥84.2m
Net income−CN¥126.2m−CN¥112.4m−CN¥170.4m−CN¥86.7m−CN¥78.7m−CN¥83.5m−CN¥113.2m−CN¥86.9m
Diluted earnings per share-0.23-0.21-0.32-0.16-0.15-0.15-0.20-0.15
Cash from operations———−CN¥107.0m−CN¥83.0m−CN¥110.0m−CN¥99.0m−CN¥82.0m
Capital spending−CN¥46.0m−CN¥3.0m−CN¥6.0m−CN¥3.0m−CN¥9.0m—−CN¥1.0m—
Free cash flow———−CN¥110.0m−CN¥92.0m—−CN¥100.0m—
Total assetsCN¥1.85bnCN¥2.00bnCN¥2.06bnCN¥2.15bnCN¥2.17bnCN¥2.16bnCN¥2.22bnCN¥2.31bn
Cash and short-term investments———CN¥1.69bnCN¥1.58bnCN¥1.52bnCN¥1.29bnCN¥1.52bn
DebtCN¥205.2mCN¥104.2mCN¥48.4mCN¥277.1mCN¥200.1mCN¥107.9mCN¥66.2mCN¥66.2m
Shareholders' equityCN¥1.35bnCN¥1.47bnCN¥1.58bnCN¥1.74bnCN¥1.82bnCN¥1.89bnCN¥1.97bnCN¥2.08bn

Financial ratios

Data as of 11 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin100.0%75.0%78.7%-6927.6%-25963.7%—
Operating margin-157.5%-188.4%-2897.8%-936955.9%-5121859.5%—
Net margin-151.3%-190.5%-2911.5%-944816.2%-5136625.8%—
Return on equity-26.6%-19.5%-16.8%-8.9%-7.8%-30.7%
Return on assets-20.4%-17.3%-15.2%-8.6%-7.6%-29.1%
Free cash flow yield-5.4%-5.5%-3.8%-2.6%-2.1%-1.8%
Revenue growth37.5%1365.6%52604.9%470.5%——
Earnings growth9.2%-4.1%62.4%4.9%-5.0%43.4%
Current ratio4.38x7.77x12.82x34.22x40.72x20.88x
Debt to equity0.03x0.03x0.03x0.00x0.00x0.00x
Equity ratio76.6%88.6%90.7%96.4%97.2%94.9%
Interest coverage-52.75x-53.98x-125.03x-269.61x-421.61x-2212.01x
R&D as a share of sales102.0%154.7%2650.9%934639.3%4170181.5%—
Buybacks as a share of market value4.8%1.9%5.2%-34.7%0.8%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue2098.1%——
Operating income20.7%12.0%—
Net income19.4%11.1%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin89.5%88.8%——
Operating margin-171.1%-298.7%——
Net margin-167.8%-294.5%——

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022
Price to earnings-14.8-10.0-15.5-27.8
Price to sales22.419.1452.5—

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.